You just read:

Vtesse Announces Dosing of First Patient in Australia in Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease

News provided by

Vtesse, Inc.

Jan 10, 2017, 16:00 ET